PolyNovo (ASX:PNV) says goodbye to COO Anthony Kaye

Company News

by Lauren Evans

PolyNovo (ASX:PNV) announced its chief operating officer Dr Anthony Kaye has resigned. Dr Kaye is returning to bio tech firm CSL, where he originally came from. 

The medical device company noted that Dr Kaye completed and commissioned PolyNovo's new hernia product manufacturing facility.

“Anthony joined PolyNovo at a critical time to help complete our new manufacturing facility, oversee the commissioning of new machinery and put in place a team to deliver best practice production processes and costs," said managing director Paul Brennan.

Shares in PolyNovo (ASX:PNV) are trading 4.8 per cent lower at $1.93. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.